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Abstract: 
Objective: To determine the prevalence of the 3 components of the female athlete triad 
[disordered eating, menstrual dysfunction, low bone mineral density (BMD)] and their 
relationships with brachial artery flow-mediated dilation in professional dancers. 
Design: Prospective study. 
Setting: Academic institution in the Midwest. 
Participants: Twenty-two professional ballet dancers volunteered for this study. 
Interventions: The prevalence of the female athlete triad and its relationship to 
endothelial dysfunction. 
Main Outcome Measures: Subjects completed questionnaires to assess disordered 
eating and menstrual status/history. They also completed a 3-day food record and wore an 
accelerometer for 3 days to determine energy availability. Serum baseline thyrotropin, prolactin, 
and hormonal concentrations were obtained. Bone mineral density and body composition were 
measured with a GE Lunar Prodigy dual-energy X-ray absorptiometry. Endothelial function was 
determined as flow-mediated vasodilation measured by high-frequency ultrasound in the brachial 
artery. An increase in brachial diameter <5% to hyperemic flow stimulus was defined a priori as 
endothelial dysfunction. 
Results: Seventeen dancers (77%) had evidence of low/negative energy availability. 
Thirty-two percent had disordered eating (EDE-Q score). Thirty-six percent had menstrual 
dysfunction and 14% were currently using hormone contraception. Twenty-three percent had 
evidence of low bone density (Z-score < -1.0). Sixty-four percent had abnormal brachial artery 
flow-mediated dilation (<5%). Flow-mediated dilation values were significantly correlated with 
serum estrogen and whole-body and lumbar BMD. All the 3 components of the triad plus 
endothelial dysfunction were present in 14% of the subjects. 
Conclusions: Endothelial dysfunction was correlated with reduced BMD, menstrual 
dysfunction, and low serum estrogen. These findings may have profound implications for 
cardiovascular and bone health in professional women dancers. 
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Introduction 
There are an estimated 38,000 professional dancers in the United States and countless 
amateur or recreational dancers. This unique group of athletes is at high risk for developing the 
female athlete triad (triad)1,2 due to the aesthetic nature of the sport.3 The first American College 
of Sports Medicine triad position statement was published in 1997 describing the interrelated 
conditions of disordered eating, amenorrhea of hypothalamic origin, and osteoporosis. In 2007, 
the American College of Sports Medicine revised their position statement on the triad, including 
updated recommendations for screening, diagnosis, prevention, and treatment. One new aspect 
of the position statement is a comprehensive and expanded definition of each component of the 
triad from a spectrum of health to disease, including energy availability (EA) (with or without 
disordered eating), menstrual function, and bone health.1 Low/negative EA has been determined 
to be the key disorder underlying the relationship to the other components.1,4 
The new position statement also includes seminal research from our group that 
demonstrated an association between athletic amenorrhea and a reduction in brachial artery 
flow-mediated dilation (FMD).1,5 Abnormal brachial dilation has been shown to have a positive 
predictive value (95%) for coronary endothelial dysfunction.6 In addition, Schachinger et al7 have 
shown that coronary endothelial vasodilator dysfunction predicts long-term atherosclerotic 
disease progression and cardiovascular event rates. Therefore, the assessment of brachial 
endothelial function can provide valuable information about cardiovascular disease risk in an 
otherwise healthy athletic population. 
No studies have examined the relationship of all the 3 components of the triad while 
simultaneously assessing brachial artery FMD in professional dancers, a high-risk group for the 
triad. Therefore, the purpose of this study is to determine the prevalence of the 3 components of 
the triad [disordered eating (with/without low/negative EA), menstrual dysfunction, low bone 
mineral density (BMD)] and their relationships with brachial artery FMD. 
 
Methods 
Subjects and Experimental Design 
This study was reviewed and approved by multi-institutional human subjects’ internal 
review boards (Medical College of Wisconsin, Marquette University, Milwaukee, Wisconsin). 
Inclusion criteria included professional female dancers, aged 18 to 35 years, from a single 
company in the Midwest. Exclusion criteria included a history of heart disease, vascular disease, 
hypertension, diabetes, hypercholesterolemia, chromosomal disorder, current pregnancy, 
pituitary tumor, anomalies of the reproductive system, and thyroid disease. Subjects on a cardiac, 
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cholesterol, hypertension, or thyroid medication were excluded. Subjects were not excluded 
based on ethnicity. Twenty-two women met the inclusion criteria and completed the study. No 
women were excluded based on our criteria. The study was explained in person, and an 
informed consent was obtained. Medical histories were obtained by questionnaires and 
interview. 
 
Disordered Eating 
Energy availability is the amount of dietary energy remaining for other bodily functions 
after exercise energy expenditure1,4 and has been demonstrated to be the key in terms of 
initiating the neuroendocrine cascade associated with the triad.1,4 Energy intake was determined 
from a prospective 3-day food diary recorded during 2 weekdays and 1 weekend day during the 
training season. A registered research dietitian met with each dancer for education and training 
in proportions or size of food servings, proper recording of foods, and the use of the food diary in 
general. Dietary analysis was performed by the research dietician using Nutrition Data System 
for Research software version 2007 (developed by the Nutrition Coordinating Center, University 
of Minnesota, Minneapolis, Minnesota) to determine total calories, total composition of fat, 
protein, carbohydrates, and micronutrient content. Subjects were encouraged to weigh their food 
portions for recording. 
Estimated energy expenditure during daily exercise was determined by use of an 
Actigraph accelerometer (Actigraph GT1M Monitor; Actigraph, Pensacola, Florida). 
Accelerometers were individually calibrated for each subject at 2 different self-selected 
intensities of exercise with the Cortex metabolic system (Cortex MetaLyzer 3B Version 2.1; 
Cortex, Leipzig, Germany). Accelerometers were worn continuously for 72 hours, and the total 
kilocalories expended were calculated. Accelerometer has been shown to be a valid device to 
measure energy expenditure.8,9 
Energy availability was calculated from the subjects’ caloric intake minus the amount of 
exercise energy expended over the same time as determined from the accelerometer. 
Low/negative EA was defined as a negative value. At the end of the study, each subject met with 
the dietician to review her results. 
Eating habits and attitudes were assessed by the eating disorder examination 
questionnaire (EDE-Q). The EDE-Q is a shorter version of the eating disorder examination10 and 
is designed for self-report. The EDE-Q is composed of 4 scales [weight concern, shape concern, 
eating concern, dietary restraint] and has a global score or mean composite score of the 4 
subscales. Scores ranging from 0 to 6 on a Likert scale correspond to the number of days the 
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respondent has experienced a specific attitude, feeling, or behavior during the past 4 weeks. 
Athletes were classified as having disordered eating if they had a mean score of ≥4.0 on any 
subscale. A cutoff score of 4.0 indicates that a specific attitude or behavior was reported on more 
than half of the past 28 days, which was used to define disordered eating because it has been 
shown to be predictive of eating disorders.10 Previously, scores of ≥4.0 have been reported to 
correspond to the 80th to 95th percentiles from reference norms for adolescent girls.10 Based on 
this scoring rubric, athletes were divided into 2 groups: disordered eating (elevated EDE-Q score) 
or normal EDE-Q score. 
 
Menstrual Status 
Self-administered questionnaires were used to determine age of menarche, number of 
periods per year, number of days between periods, skipped periods, history of thyroid disease or 
pituitary tumor, and use and type of birth control. A formal interview regarding menstrual status 
and medical history was conducted by the principal investigator. For the purpose of this study, 
eumenorrhea or regular cycling was defined as menstrual bleeding every 28 to 30 days. Primary 
amenorrhea was defined as the absence of menarche by age 15 and secondary amenorrhea as 
the cessation of menses for >3 consecutive cycles after onset of menarche. Oligomenorrhea was 
represented by menstrual cycles with intervals >35 days. 
 
Hormonal Profiles 
To determine the role of reproductive and metabolic hormones and to rule out potential 
medical or gynecological causes of amenorrhea, follicle-stimulating hormone, luteinizing 
hormone, progesterone, estrogen, thyrotropin, prolactin, and beta-human chorionic gonadotropin 
were measured. Hormone concentrations were measured in plasma obtained from whole 
venous blood drawn in the early follicular phase of the menstrual cycle (days 4-8) in the early 
morning after an 8-hour fast. Amenorrheic dancers followed the same protocol except, since they 
were not having menstrual cycles, they were tested at a convenient time. Samples were 
processed within hours and kept on ice until transported to the laboratory for analysis. All 
measurements were made in a clinical certified laboratory (College of American Pathologists and 
Clinical Laboratory Improvement Amendments). 
 
Bone Mineral Density 
Each subject underwent BMD measurement by dual-energy X-ray absorptiometry using a 
GE Lunar Prodigy densitometer, version 7.52.002 (Madison, Wisconsin). Calibrations with a 
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standard phantom spine were performed daily. All measurements were performed by the same 
trained professional. The coefficient of variation of the phantom for more than a 6-month period 
was 0.29%. Bone mineral density (gram/square centimeter) of the lumbar spine (L1-L4), total left 
hip, left femoral neck, left trochanter, and total body were measured for each subject. 
 
Cardiovascular Status 
Brachial artery FMD and velocity were determined by techniques previously used in this 
laboratory.5 Subjects were studied in a supine resting position after an 8-hour fast in a 
temperature-controlled room. Systemic arterial pressure was periodically monitored in the 
nondominant arm with an automated sphygmomanometer. Subjects were instrumented for 
continuous recording of electrocardiogram, heart rate, and intermittent blood pressure. All 
subjects were tested at approximately the same time of day with eumenorrheic subjects studied 
in the early follicular phase of the menstrual cycle (days 4-8). Amenorrheic subjects were tested 
randomly as scheduled but also in the early morning. 
 
Statistics 
The relationship between menstrual status (eumenorrhea, oligomenorrhea, and 
amenorrhea) and FMD was evaluated using the nonparametric Jonckheere–Terpstra exact test 
for trend after excluding 3 subjects using hormonal birth control. The relationship between 
estrogen concentrations and FMD was assessed using Spearman rank correlation for the same 
population with an additional exclusion of 1 ovulating subject. Pearson correlation coefficient was 
used to determine a correlation among FMD, BMD, and EA. 
 
Results 
Subject Characteristics 
Twenty-two elite dancers were consented and completed all measurements in this study. 
Dancers self-reported their ethnicity as white (n = 20), Asian (n = 1), and Hispanic (n = 1), with a 
mean (±SD) age of 23.2 ± 4.7 years. Table 1 provides descriptive demographics of the cohort.  
 
Energy Availability/Disordered Eating 
Seventeen dancers (77%) had low/negative EA (-547.8 ± 359.9 kcal/d) (Figure 1A). 
Seven dancers (32%) had elevated EDE-Q scores of >4.0 in one or more subcategories, 
accounting for a total of 14 elevated scores. Eighty-six percent either had abnormal EDE-Q 
scores and/or low/negative EA. Thirteen dancers (59%) were in a calcium deficit (-441.3 ± 347.7 
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mg/d) based on a requirement of 1500 mg/d.11 Finally, 10 (46%) were in an iron deficit (mean 
deficit of 5.5 mg/d) based on a requirement of 18 mg/d. 
 
Amenorrhea/Oligomenorrhea 
Current menstrual status is reported in Figure 1B. Most of the dancers self-reported a 
history of menstrual dysfunction. Four (18%) had a history of primary amenorrhea, 14 (64%) had 
a history of secondary amenorrhea, and 6 (27%) reported a history of oligomenorrhea. At the 
time of the study, 2 dancers were amenorrheic (9%) (2.0 ± 0.1 years) and 6 (27%) were 
oligomenorrheic. Collectively, 36% self-reported current menstrual dysfunction. Three (14%) 
were taking different forms of combination contraceptive hormones. Beta-human chorionic 
gonadotropin tests results were negative. Thyrotropin and prolactin concentrations were within 
normal limits. 
 
Bone Mineral Density 
The American College of Sports Medicine/World Health Organization (Z-score < -1.0) 
criteria are reported (Figure 1C).1,12 Five dancers (23%) had low BMD in 1 or more locations. 
International Society for Clinical Densitometry (Z-score < -2.0) criteria were not met by any of our 
dancers in any anatomic locations studied.13 Five (23%) had low BMD in the lumbar spine 
(L2-L4), 2 (9%) had low whole-body BMD and lumbar spine, and no dancers demonstrated low 
BMD in either the left femoral trochanter or left femoral neck. Collectively, 23% had a clinically 
significant decrease in BMD at least at 1 site as determined by the dual-energy X-ray 
absorptiometry. 
 
Vascular Reactivity 
Brachial artery data are summarized in Table 2 and Figure 2. Table 2 includes data on 
heart rate, systolic arterial pressure, diastolic arterial pressure, temperature, relative humidity, 
baseline brachial artery diameter, FMD, and peak change in flow velocity. Subjects were 
subsequently divided into normal and reduced FMD as defined by <5% dilation in response to an 
ischemic challenge14,15 and unpublished norms for our laboratory. Brachial artery FMD was 
reduced in 14 dancers (64%). Baseline brachial diameters, arterial pressures, resting heart rate, 
temperature, humidity, and peak change in flow velocity were not significantly different between 
subjects with reduced and with normal FMD. 
All subjects with current menstrual dysfunction (n = 8; 36%) had a reduced FMD. A 
significant trend was found between menstrual status and FMD (Figure 3A). Amenorrheic 
 Hoch, Papanek, Szabo, Widlansky, Schimke, Gutterman 7 
dancers (n = 2) had a mean FMD of 1.8% ± 0.4. Oligomenorrheic dancers (n = 6) had a mean 
FMD of 3.1% ± 1.7%. Five of the eumenorrheic dancers also had a reduced FMD (3.0% ± 1.8%). 
A significant difference was found (P = 0.016) for FMD between the amenorrheic group (n = 2) 
and total eumenorrheic group (n = 11) (1.8% ± 0.4% vs 5.9% ± 3.0%). Furthermore, lower 
estrogen values were associated with significantly lower FMD (P = 0.026) (Figure 3B). Subjects 
with the lowest Z-score also had the lowest FMD. The strongest positive correlation (R = 0.50; P 
= 0.02) was between FMD and whole-body Z-score (Figures 3C, D). L2 to L4 Z-score also 
correlated to FMD (R = 0.46; P = 0.03) (Figure 3C). Interestingly, there was no correlation 
between FMD and EA (Figure 3E).  
 
Prevalence of Triad Components 
In the present study of elite dancers, 3 (14%) had all the 3 components of the triad and 
reduced flow-mediated vasodilation. An additional 5 (23%) had 3 of the 4 components. Three 
(14%) had 2 components, 8 (36%) had at least 1 component, and 3 (14%) did not have a single 
component. 
 
Discussion 
This is the first study to report on the prevalence of all the 3 components of the triad plus 
the emerging component of endothelial dysfunction manifested by reduced brachial artery FMD 
in professional ballet dancers. The percentage of dancers who met all the 3 components of the 
triad and reduced FMD was 14% (3 of 22) with an additional 23% (5 of 22) meeting the criteria 
for 3 of the 4 components. This is much higher than that in the study by Torstveit and 
Sundgot-Borgen16 of elite Norwegian endurance athletes, where only 4.3% (N = 8) met the 
criteria for 3 components of the triad. Although none of those athletes were professional dancers, 
6 competed in leanness type sports (running, swimming, biathlon, and bicycling). The prevalence 
in our population is also much higher than leanness sports (track, cross-country, and 
swimming).18 To previously reported in high school athletes (1%)17,18 from date, the majority of 
studies on dancers have looked primarily a variety of sports in which 62% (N = 106) competed in 
at the disordered eating or the link between amenorrhea and low BMD,19–21 and none have 
investigated the prevalence of endothelial dysfunction. Of the studies specifically designed to 
determine the prevalence of all the 3 components of the triad simultaneously, the majority have 
focused on elite Norwegian endurance athletes,16,22 college athletes,23 or high school 
athletes,17,18 across a spectrum of sports. The prevalence rate of 14% for the triad plus reduced 
FMD in elite dancers suggests that the changes in vascular function coexist in sufficient 
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frequency that a tetrad of components better describes these athletes.  
 
Flow-Mediated Dilation 
No studies have investigated the prevalence of reduced FMD in professional dancers, a 
group known to be at high risk for athletic amenorrhea.21,24 Previously, we reported reduced 
brachial artery FMD in collegiate runners with amenorrhea (mean FMD, 1.08% ± 0.91).5 Similarly, 
Rickenlund et al25 reported a reduced mean FMD of 1.1% in endurance athletes from Sweden. 
These results are similar to our amenorrheic (n = 2; mean FMD, 1.8% ± 0.4) and oligomenorrheic 
dancers (n = 6; mean FMD, 3.1% ± 1.7) in this study. 
The decrease in reactive hyperemic response, although consistent with our previous 
work in runners, is surprising. Classically, exercise training enhances endothelium-dependent 
vasodilation in peripheral arteries. Elite dancers use both upper and lower extremities for 
prolonged periods. However, previous studies26 have shown that elite dancers have a Vሶ oଶmax in 
the range of nonendurance athletes. Therefore, the decreased FMD response may be partially 
due to suboptimal aerobic fitness. Future studies should measure oxygen consumption directly 
to better evaluate this variable. 
This study represented a sample of women displaying heterogenous hormonal 
disturbances and 3 subjects taking hormone contraceptives. However, all amenorrheic and 
oligomenorrheic dancers in this study (8 of 22) had low FMD. Low estrogen concentrations were 
correlated with low FMD. However, 5 of the 11 eumenorrheic and the 2 dancers using hormone 
contraception also had a reduced FMD, indicating that FMD is not simply a function of circulating 
estrogen concentrations. Furthermore, of the 17 subjects with low/negative EA (-547.8 ± 359.9 
kcal/d), 71% demonstrated reduced FMD. 
These data suggest that endothelial dysfunction is a complex process, which is not solely 
determined by estrogen concentrations. It seems that the regulation of flow-mediated 
vasodilation, a direct index of endothelial function, may be an integration of menstrual status, and 
thus hormone concentrations, aerobic fitness, and EA. Additional nutrient differences may also 
play a role but have yet to be investigated. The relationship between menstrual status/estrogen 
concentrations and FMD is statistically and clinically relevant. Not only is amenorrhea associated 
with reduced BMD but it is also associated with reduced FMD and potentially an increased risk 
for cardiovascular disease in otherwise healthy young women.  
Three dancers had all 4 components of what we suggest is a tetrad of coexisting 
conditions. This is much higher than other studies examining only 3 components of the triad.16–18 
We hypothesize that vascular endothelial function is modulated by dietary nutrient content, EA 
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(both intake and expenditure), estrogen concentrations, and aerobic condition. The ability to 
appropriately vasodilate in response to flow is vital not only for facilitating athletic performance 
and recovery but also in terms of vascular health. The high incidence of abnormal brachial artery 
FMD is alarming, and additional work is required to determine whether these changes are 
predictive of future cardiac and vascular disease because they are in other populations.27 Further 
studies are needed to ascertain the relationship of decreased FMD with cardiac function and 
human performance as well as underlying mechanisms.  
There are several limitations to this study. The sample size is very small, making multiple 
comparisons unachievable. However, the major methodological flaw in this study is pooling 
statistical analyses of athletes using hormonal contraceptives together with those who are not. 
Furthermore, the authors had access to 1 professional dance company, making it difficult to 
determine true prevalence. In addition, we had no control group. However, finding age-matched 
and body mass index–matched controls proved to be unattainable. Finally, Vሶ oଶ testing would be 
valuable to measure because this is a known determinant of FMD.  
 
Conclusions 
Our data show that the prevalence of the 4 components (triad and reduced endothelial 
function) is comparably high in professional dancers (14%). Abnormal FMD occurred in 64% of 
our population. Low FMD was associated with low estrogen concentrations and reduced BMD. 
Collectively, this suggests that it is not simply a function of circulating plasma estrogen 
concentrations but is more complex and multifactorial. Although additional studies are required to 
determine mechanisms, the high incidence of low/negative EA, BMD, and menstrual dysfunction 
accentuates target interventions to address this issue in the dance community and raises 
concern regarding long-term impact on the vascular system. 
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Appendix 
Figure 1: Prevalence of the Female Athlete Triad 
 
 
 
A. Percentage of dancers with 
disordered eating defined as calorie 
deficit or abnormal eating disorder 
examination questionnaire score. 
Calcium deficit based on 1500 mg and 
iron deficit based on 18 mg is also 
reported. 
 
 
 
 
B. Current menstrual status based on 
questionnaire, interview, and blood 
work. 
 
 
 
 
C. Bone mineral density in the 
dancers. A total of 5 subjects had 
reduced bone mineral density (BMD). 
Two subjects had reduced BMD in 
both the lumbar spine and whole 
body. 
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Figure 2: Brachial Artery FMD Response to Ischemia 
 
 
 
Fourteen dancers had reduced FMD (defined a priori as <5%),14,15 and 8 dancers had normal 
FMD. 
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Figure 3: Correlations with Flow-Mediated Dilation (FMD) 
 
 
 
A. Relationship between menstrual status and FMD. All the subjects with oligomenorrhea and amenorrhea 
had abnormal FMD (P = 0.015). 
B. Correlation between estrogen concentration (pictogram/milliliter) and FMD. A low estrogen 
concentration correlated with a low FMD (P = 0.026). 
C. Correlation between lumbar spine (L2-L4) bone mineral density (BMD) and FMD. A low BMD Z-score 
correlated with a low FMD (P = 0.033). 
D. Correlation between whole-body Z-score and FMD. A low BMD Z-score correlated with a low FMD (P = 
0.018). 
E. Correlation between energy expenditure (kilocalories) and FMD. There was no correlation between 
energy expenditure and FMD (P = 0.52). 
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Table 1: Physical Characteristics 
 
 
 
Values are mean ± SD unless otherwise indicated. 
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Table 2: Brachial Artery Studies 
 
 
 
Values are mean ± SD unless otherwise indicated. 
FMD, flow-mediated dilation. 
